z-logo
Premium
The possible association between serum interleukin 8 and acute urinary retention in Chinese patients with benign prostatic hyperplasia
Author(s) -
Wu Di,
Tang HaiXiao,
Wu Yu,
Qian SuBo,
Xu Ding,
Qi Jun
Publication year - 2020
Publication title -
andrologia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.633
H-Index - 59
eISSN - 1439-0272
pISSN - 0303-4569
DOI - 10.1111/and.13763
Subject(s) - medicine , hyperplasia , receiver operating characteristic , urinary retention , logistic regression , urology , biomarker , gastroenterology , prospective cohort study , urinary system , gynecology , biochemistry , chemistry
Acute urinary retention (AUR) is one of the progressive manifestations of benign prostatic hyperplasia (BPH). This cross‐sectional study was conducted to analyse the possible association between serum interleukin 8 (sIL‐8) and AUR in BPH patients to provide evidence of sIL‐8 as a potential biomarker for the prediction of AUR. The relationship between sIL‐8 levels and AUR was evaluated by logistic regressions in 245 ageing Chinese men with BPH. The discriminant validity of sIL‐8 and the optimal cut‐off value were determined by a receiver operating characteristic curve. The levels of sIL‐8 increased significantly in BPH patients with AUR ( p  < 0.001). The sIL‐8 concentration was positively correlated with AUR in BPH patients (OR = 1.024, 95% CI: 1.009–1.040, p  = 0.002). The correlation with AUR in the group with a high sIL‐8 level (≥43.05 pg/ml) was significantly enhanced (OR = 8.853, 95% CI: 2.433–32.205, p  = 0.001). The sIL‐8 level correlated with AUR in Chinese BPH patients independently. As a possible predictor, sIL‐8 may contribute to the screening of high‐risk populations for AUR to create opportunities for the early effective interventions to improve prognosis and enhance the quality of life. Prospective studies are needed to support all these results.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here